Corvert

Active Ingredient(s): Ibutilide
FDA Approved: * December 28, 1995
Pharm Company: * PHARMACIA AND UPJOHN
Category: Irregular Heartbeat (Arrhythmia)

Ibutilide is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. It exerts its antiarrhythmic effect by induction of slow inward sodium current, which prolongs action potential and refractory period (physiology) of myocardial cells. Because of its Class III antiarrhythmic activity, there should not be concomitant administration of Class Ia and Class III agents. Ibutilide is marketed as Corve... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Corvert .1 mg/ml Intravenous Injection, Solution
NDC: 0009-3794
Labeler:
Pharmacia and Upjohn Company